Institute of Health Carlos III granted the project “Targeted exonic next generation sequencing for the molecular diagnosis and cell free tumor DNA analysis as screening method for patients with DLBCL” in the call for grants Health Research and Development Strategy 2016 File Nº: PI16/01397 with the amount of 98.615€. The research project is led by Dr. Santiago […]
This week the journal Science has published in the editorial a paper in which have collaborated researchers from the University Hospital Marqués de Valdecilla and the University of Cantabria. The work has also been referenced in BioCentury. This reference marks a real milestone and points out the enormous interest and projection of the discoveries that […]
Our ability to control infectious diseases is continuously being eroded by antimicrobial resistance, a current major health problem worldwide. A large proportion of the research activities in our group is related to the study of physiological and biochemical aspects of the mechanisms of resistance to antimicrobial agents in bacteria. We consider clinical relevant Enterobacteria and […]
Nowadays, osteoporosis due to the progressive aging of the population, is becoming one of the most frequent diseases of our time. Decreased quality of life (for example, inability to walk again after a hip fracture) and the increase in mortality it determines, justifies intensive research efforts. IDIVAL Bone and Lipid Metabolism Group, researchers at the […]
Researchers belonging to the Valdecilla Hospital and the University of Cantabria, of the IDIVAL Group Cytokines and growth factors in pathological tissue plasticity phenomena have collaborated in a study published last Monday in the prestigious journal Nature Medicine in which it is shown that the pharmacological inhibition of The NOS2 protein not only prevents pathological dilatation […]
T lymphocytes are blood cells whose mission is to destroy the malignant cells that affect our organism. They fight against diseased cells that sometimes originate in organs or those that have been infected by viruses. However, when they undergo certain genetic alterations they can cause tumors such as peripheral T-cell lymphomas, which have a very […]
The Board of IDIVAL at its meeting on December 16th approved the update of its composition with the incorporation of the following researchers: – Marcos López Hoyos. Coordinator of the Transplant Area of Organs and Tissues and New Therapies. Head of Immunology Service. University Hospital Marqués de Valdecilla. It replaces Dr. Manuel Arias, recently retired. […]
Frontiers in Immunology, the first most cited magazine in the field of Immunology and with high ranking, publishes in its open-access edition a coordinated work between the IDIVAL Research Institute (Group of Nanovacunas and cellular vaccines based on Listeria), Marqués de Valdecilla University Hospital (Microbiology Service and Section of Infectious Diseases) and the University Hospital […]
After analyzing more than 41,000 people (21,000 individuals with schizophrenia and 20,000 without it), the largest genomic study of schizophrenia to date has managed to isolate rare genetic variations that increase the risk of this disease. This study, recently published in Nature Genetics, has been conducted and led by the University of San Diego (USA), […]
The Massachusetts Institute of Technology (MIT) is the best Technical University in the world. Rafael Reif, president of the MIT, said in an interview for the Spanish newspaper El País on the 24th of October: “There are people from 152 countries in the MIT. Almost 80% of the nations are represented here. MIT has a […]
